about
Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammationClade, Country and Region-specific HIV-1 Vaccines: Are they necessary?Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screensAn in vivo cytotoxicity threshold for influenza A virus-specific effector and memory CD8(+) T cellsADAMTS5 Is a Critical Regulator of Virus-Specific T Cell ImmunityMolecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motifInfluenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection.Timing of immune escape linked to success or failure of vaccination.Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.Comparison of influenza and SIV specific CD8 T cell responses in macaquesProtection and compensation in the influenza virus-specific CD8+ T cell responseLocation rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory.HIV vaccine rationale, design and testing.HIV vaccines: brief review and discussion of future directions.Promotion of Hendra virus replication by microRNA 146aTrivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.Tracking phenotypically and functionally distinct T cell subsets via T cell repertoire diversity.HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.Killer T cells in influenza.Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy.Influenza reverse genetics: dissecting immunity and pathogenesis.Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses.Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3.miRNA modulation of SOCS1 using an influenza A virus delivery system.Influenza A virus-specific CD8 T-cell responses: from induction to function.Enhanced immunogenicity following miR-155 incorporation into the influenza A virus genome.Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination.Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation.Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.Unique IL-13Rα2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity.P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques.Diversity and clonotypic composition of influenza-specific CD8+ TCR repertoires remain unaltered in the absence of Aire.Finding multiple needles in one immune haystackLong lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategyEvolution of high pathogenicity of H5 avian influenza virus: haemagglutinin cleavage site selection of reverse-genetics mutants during passage in chickensGeneration of recombinant influenza A viruses lacking immunodominant CD8+ T cell epitopes
P50
Q21090498-7B65DA15-3F0A-4597-BB5D-0BF3DF5E2F4CQ24803275-D4F0C976-A12E-4957-BFF1-248D46B381F9Q26852062-E63D9C20-5C41-426D-8022-693CD6B376DCQ28284174-108046F5-A3E3-4A9D-B3B8-59BF68C13079Q28553566-825E865D-EA9F-405B-9ACD-6A7C71B3610BQ30380274-7FEB8F36-8341-4801-AE11-24BB9D942E73Q30430936-BAAE8CA9-A239-4701-8881-4C725CC6DDDAQ33700493-7F439A57-460D-4C1C-BA72-105139FA6AFAQ33707307-D51F19B9-FDF2-44A0-A213-DA8D1B4CA175Q34189478-AE80BBCA-D495-470A-99C6-858ABB5CE4EEQ35163418-FFC1B762-BE83-48CA-9ECE-8EF87B88FDE5Q35834524-5BA80621-5241-4F7D-9D27-89E42966D3A2Q36107555-03D8DB0A-664E-46EA-BB6C-6A8BE9216F48Q36198655-063079FB-BAC4-4485-BE43-E4CEE4489F34Q36759724-FB0649D0-EE74-480B-839C-330C2DD24029Q36760165-E11BB22A-DF78-47C2-9581-5E95D454E367Q36919171-BB7B522D-96E2-4EF1-A398-9DBAD3739FA9Q36991880-6E252E10-B796-4E43-A971-5695477CB43EQ37074146-EC1C47CB-43DD-49C5-B084-235317D92433Q37256687-E220B1CF-6FF5-4C19-88E3-9AD793AB6936Q37272809-DE8607BD-E88B-4CC9-80B9-C843B3CD1A6BQ37941157-342C586C-DE92-403A-A70A-24B8EDA4BDF1Q38188084-BBFEF213-C55E-4AB5-A988-4271CF19D730Q38798025-49E00881-E040-4F36-AD37-A18D742090C7Q38927479-CC11BFF6-EDDB-4ADD-9B5E-497DD1D9A08FQ38990190-2A4A5918-68A0-44BC-B351-B2F8874890D8Q39897122-5DFB10B0-5BBA-43FA-BCB7-F9CBB29DF42CQ40251328-64604E86-8738-48CE-99F8-E6C801228DD6Q41645299-915A3B2F-C0D9-4032-B9DE-73ABA69DF1C9Q43948614-2EDD3FD9-9056-4C42-AD5C-C4C8CCB9E143Q44189653-A3CD1316-2D7C-4C09-B1B6-97C96694AD76Q44990480-DB0F3199-DD70-488D-93E2-8F9F835023BEQ45381583-FE756A40-AC5F-46A9-8838-0C14A7FFEA69Q46391524-516D2CBD-F717-46C6-8B89-0FD1265518B7Q46426972-E656DF85-AFE3-40F9-B8B5-BCABE8AF88ABQ54452411-75B3EEE0-0ADA-452F-87EC-BBB00FE752B8Q55877000-8BA9A0ED-78DE-4735-A6D5-C46DCE5CDBD9Q55877037-D9FFEBC9-29CE-453B-A898-0E5B5305F4D4Q56986210-433C720A-0F15-42D8-82E5-DD8F40C1B1D9Q57082203-BE6B4295-F697-4069-B78B-55D15AF86C03
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
John Stambas
@ast
John Stambas
@en
John Stambas
@es
John Stambas
@nl
John Stambas
@sl
type
label
John Stambas
@ast
John Stambas
@en
John Stambas
@es
John Stambas
@nl
John Stambas
@sl
prefLabel
John Stambas
@ast
John Stambas
@en
John Stambas
@es
John Stambas
@nl
John Stambas
@sl
P106
P1153
6508375606
P21
P31
P496
0000-0002-5690-2551